연구성과로 돌아가기

2023 연구자 정보 (60 / 1135)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Kang, Taewoo
(Kang, T) ⓘ 		ⓘ
ⓘ
ⓘ 		[JCR상위 1.7] Prospective single-arm study of endocrine therapies with ovarian function suppression in premenopausal patients with node-positive early breast cancer with low genomic risk (INTERSTELLAR trial, KBCSG-25)
[JCR상위 1.7] Omission of breast surgery for predicted pCR patients with MRI and vacuum-assisted biopsy in breast cancer after neoadjuvant chemotherapy: A multicenter, single-arm, non-inferiority trial (OPTIMIST trial) ⓘ 		SCIE ⓘ 1.7 ONCOLOGY ⓘ ⓘ
Kang, Yoon-Koo
(Kang, YK) ⓘ 		Univ Ulsan, Dept Oncol, Coll Med, Asan Med Ctr, Seoul, South Korea
Univ Ulsan, Asan Med Ctr, Coll Med, Seoul, South Korea ⓘ 		ABL-4264-2022
Kang, Yoon-Koo ⓘ
ⓘ 		[JCR상위 1.7] ATTRACTION-5: A phase 3 study of nivolumab plus chemotherapy as postoperative adjuvant treatment for pathological stage III (pStage III) gastric or gastroesophageal junction (G/GEJ) cancer
[JCR상위 13.6] Long-term outcomes of a phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumors of the stomach
[JCR상위 1.7] Phase 2 study of bavituximab (bavi), a first-in-class antibody targeting phosphatidylserine (PS), plus pembrolizumab (P) in advanced gastric or gastroesophageal junction (GEJ) cancer
[JCR상위 74.7] Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/Gastroesophageal Adenocarcinoma ⓘ 		SCIE ⓘ 1.7 ONCOLOGY
GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY ⓘ 		hkyang@snu.ac.kr;
ykkang@amc.seoul.kr; ⓘ
Kelley, Robin Kate
(Kelley, RK) ⓘ 		ⓘ
ⓘ
ⓘ 		[JCR상위 1.7] Outcomes by occurrence of immune-mediated adverse events (imAEs) with tremelimumab (T) plus durvalumab (D) in the phase 3 HIMALAYA study in unresectable hepatocellular carcinoma (uHCC) ⓘ SCIE ⓘ 1.7 ONCOLOGY ⓘ ⓘ
Kendrick, Stuart
(Kendrick, S) ⓘ 		GSK, Stevenage, Herts, England ⓘ
ⓘ
ⓘ 		[JCR상위 1.7] Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report ⓘ SCIE ⓘ 1.7 GASTROENTEROLOGY & HEPATOLOGY ⓘ robert.c.elston@gsk.com; ⓘ
Kim, Eun-Kyu
(Kim, EK) ⓘ 		ⓘ LNQ-3974-2024
Kim, Eun-Kyu ⓘ
ⓘ 		[JCR상위 1.7] Prospective single-arm study of endocrine therapies with ovarian function suppression in premenopausal patients with node-positive early breast cancer with low genomic risk (INTERSTELLAR trial, KBCSG-25) ⓘ SCIE ⓘ 1.7 ONCOLOGY ⓘ ⓘ
Kim, Ho Young
(Kim, HY) ⓘ 		Hallym Univ, Hallym Univ Sacred Heart Hosp, Dept Hematol Oncol, Coll Med, Anyang Si, South Korea ⓘ HTR-7982-2023
Kim, Ho-Young ⓘ
ⓘ 		[JCR상위 1.7] Clinical outcomes of extramammary Paget's disease in Korea: A multicenter, retrospective study
[JCR상위 46.7] Treatment outcomes of advanced/metastatic extramammary Paget's disease in Korean patients: KCSG-RC20-06 ⓘ 		SCIE ⓘ 1.7 ONCOLOGY ⓘ imbs@paik.ac.kr; ⓘ
Kim, Hye Sung
(Kim, HS) ⓘ 		Northwestern Mem Hosp, Dept Internal Med, Chicago, IL 60611 USA ⓘ LQV-0440-2024
Kim, Hye Sung ⓘ 		0000-0002-7256-7597
Kim, Hye Sung ⓘ 		[JCR상위 1.7] Incidence, landscape and survival outcome of de novo malignancy after double lung transplantation.
[JCR상위 19.0] A Comprehensive Landscape of De Novo Malignancy After Double Lung Transplantation
[JCR상위 1.7] Machine learning models based on radiomics features to predict treatment response, biomarker status, and bone metastasis in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) ⓘ 		SCIE ⓘ 1.7 ONCOLOGY
SURGERY;TRANSPLANTATION ⓘ 		ychae@nm.org; ⓘ
Kim, Hyeonseon
(Kim, H) ⓘ 		ⓘ
ⓘ
ⓘ 		[JCR상위 1.7] Machine learning models based on radiomics features to predict treatment response, biomarker status, and bone metastasis in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) ⓘ SCIE ⓘ 1.7 ONCOLOGY ⓘ ⓘ
Kim, Hyojeong
(Kim, H) ⓘ 		Pusan Natl Univ, Dept Internal Med, Div Hematooncol, Sch Med, Busan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.7] Clinical outcomes of extramammary Paget's disease in Korea: A multicenter, retrospective study
[JCR상위 46.7] Treatment outcomes of advanced/metastatic extramammary Paget's disease in Korean patients: KCSG-RC20-06 ⓘ 		SCIE ⓘ 1.7 ONCOLOGY ⓘ imbs@paik.ac.kr; ⓘ
Kim, Hyun-Ah
(Kim, HA) ⓘ 		ⓘ
ⓘ
ⓘ 		[JCR상위 1.7] Prospective single-arm study of endocrine therapies with ovarian function suppression in premenopausal patients with node-positive early breast cancer with low genomic risk (INTERSTELLAR trial, KBCSG-25) ⓘ SCIE ⓘ 1.7 ONCOLOGY ⓘ ⓘ
Kim, Ilhwan
(Kim, I) ⓘ 		Inje Univ, Haeundae Paik Hosp, Dept Internal Med, Div Oncol,Coll Med, Pusan, South Korea ⓘ AGF-2385-2022
Kim, In-Ryoung ⓘ
ⓘ 		[JCR상위 1.7] Serum vitamin D3 levels and overall survival (OS) in patients (pts) with advanced biliary tract cancer (BTC): Analysis of the NIFTY trial cohort.
[JCR상위 3.6] Treatment With Liposomal Irinotecan Plus Fluorouracil and Leucovorin for Patients With Previously Treated Metastatic Biliary Tract Cancer The Phase 2b NIFTY Randomized Clinical Trial ⓘ 		SCIE ⓘ 1.7 ONCOLOGY ⓘ yooc@amc.seoul.kr; ⓘ
Kim, Jeong Eun
(Kim, JE) ⓘ 		ⓘ
ⓘ
ⓘ 		[JCR상위 1.7] Clinical outcomes of extramammary Paget's disease in Korea: A multicenter, retrospective study ⓘ SCIE ⓘ 1.7 ONCOLOGY ⓘ ⓘ
Kim, Ku Sang
(Kim, KS) ⓘ 		ⓘ
ⓘ
ⓘ 		[JCR상위 1.7] Omission of breast surgery for predicted pCR patients with MRI and vacuum-assisted biopsy in breast cancer after neoadjuvant chemotherapy: A multicenter, single-arm, non-inferiority trial (OPTIMIST trial) ⓘ SCIE ⓘ 1.7 ONCOLOGY ⓘ ⓘ
Kim, Kyu-Pyo
(Kim, KP) ⓘ 		ⓘ GQH-5608-2022
Kim, Hyunho ⓘ
ⓘ 		[JCR상위 1.7] Serum vitamin D3 levels and overall survival (OS) in patients (pts) with advanced biliary tract cancer (BTC): Analysis of the NIFTY trial cohort. ⓘ SCIE ⓘ 1.7 ONCOLOGY ⓘ ⓘ
Kim, Leeseul
(Kim, L) ⓘ 		ⓘ
ⓘ
ⓘ 		[JCR상위 1.7] Machine learning models based on radiomics features to predict treatment response, biomarker status, and bone metastasis in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) ⓘ SCIE ⓘ 1.7 ONCOLOGY ⓘ ⓘ
페이지 이동: